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Abstract
g-FLUA2H is a web-based application focused on the analysis of the dynamics of influenza virus animal-to-human
(A2H) mutation transmissions. The application only requires the viral protein sequences from both the animal and
human host populations as input datasets. The comparative analyses between the co-aligned sequences of the
two viral populations is based on a sliding window approach of size nine for statistical significance and data
application to the major histocompatibility complex (MHC) and T-cell receptor (TCR) immune response
mechanisms. The sequences at each of the aligned overlapping nonamer positions for the respective virus hosts
are classified as four patterns of characteristic diversity motifs, as a basis for quantitative analyses: (i) “index”, the
most prevalent sequence; (ii) “major” variant, the second most common sequence and the single most prevalent
variant of the index, with at least one amino acid mutation; (iii) “minor” variants, multiple different sequences, each
with an incidence (percent occurrence) less than that of the major variant; and (iv) “unique” variants, each with
only one occurrence in the alignment. The diversity motifs and their incidences at each of the nonamer positions
allow evaluation of the mutation transmission dynamics and selectivity of the viral sequences in relation to the
animal and the human hosts. g-FLUA2H is facilitated by a grid back-end for parallel processing of large sequence
datasets. The web-application is publicly available at http://bioinfo.perdanauniversity.edu.my/g-FLUA2H. It can be
used for a detailed characterization of the composition and incidence of mutations present in the proteomes of
influenza viruses from animal and human host populations, for a better understanding of host tropism.
Introduction
Influenza has a history as one of the world’s most serious
pathogens, with yearly regional infections and episodic
global pandemics. Influenza viruses belong to the Ortho-
myxoviridae family of RNA viruses and occur as three
major types: influenza A, infectious in birds and some
mammals, including humans [1]; influenza B, a genus that
infects only humans and seals [2]; and influenza C, a rare
type that is known to have infected human and pigs [3].
Proliferation of influenza A is predominantly in avian
hosts with very rapid mutation, resulting in a “quasispe-
cies” [4], a vast number of viruses that are genetically
related but differ in the amino acid sequences of the viral
proteins. These mutations are a classic example of Darwi-
nian evolution [5]; they occur in a random fashion and the
variant viruses that have the best genetically endowed
combination of efficient infection, rapid replication, and
greatest survival become the dominant populations. The
survival properties include virus escape from the immune
responses of humans previously infected or immunized
with an earlier virus strain.
Human infections by influenza A viruses commonly
occur yearly, with a seasonal peak incidence [6], usually
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as a mild disease, but for some, as a more severe illness
that may be fatal. A major complication is the occur-
rence of global pandemics resulting from the emergence
of highly infectious subtypes of the virus, particularly
those capable of human-to-human transmission. The
history of influenza pandemics began with the H1N1
“Spanish Flu” strain of 1918-1919 that killed an esti-
mated fifty million people [7]. This was followed by
other less severe strains, the H2N2 “Asian influenza” of
1957-1958, H3N2 “Hong Kong flu” of 1968-1969, and
H5N1 “bird flu” in 2006-2007, and recently the H1N1
“swine flu” of 2009-2010. It thus appears inevitable that,
without means to prevent influenza infection, another
pandemic will occur within the foreseeable future. It is
simply a matter of chance that the mutations responsi-
ble for the infectivity and pathogenicity of a particular
influenza virus in animals does not include the ability to
efficiently infect humans with human-to-human trans-
mission. If a strain comparable to that of the 1918 pan-
demic was to occur, the global consequences are
inconceivable.
Sequence change (mutation) events can transform an
animal-origin virus into a human virus, with varying
levels of fitness to survive in the new host [7]. A num-
ber of mutations that facilitate the transmission from
animal to human hosts have been described for the
influenza A viral proteome. For example, specific amino
acid substitutions can alter the host receptor binding
site and specificity of hemagglutinin (HA) protein, a
major determinant of host tropism, for preference from
avian to human sialic acid linkages [1]. Additionally, a
single amino acid change at position 627 of the viral
polymerase complex subunit PB2 was found to enhance
replication in human host [8]. There remains, however,
the need for a comprehensive identification of sequence
changes that allow or enhance human infection, with
potential applications to influenza virus surveillance and
possibly to prevention or treatment of human infection.
A number of computational models have been reported
that discriminate between animal and human influenza A
viruses based on molecular patterns in protein sequences
[9-12] and genomic signatures [13]. Although these mod-
els are potentially useful for predicting interspecies trans-
mission of influenza viruses, there is still a great difficulty
in deciphering adaptation of viruses that show mixed
signatures of both animal and human hosts. There
remains the need for a greater understanding of the viral
sequence diversity and the dynamics of sequence change,
including the composition and incidence of mutations
between the viral host populations.
Herein, we present g-FLUA2H, a web-based application,
with a grid-backend, to analyze the dynamics of animal-
to-human (A2H) mutation transmission for influenza
viruses. The application only requires the viral protein
sequences from both the animal and human host popula-
tions as input datasets. g-FLUA2H is facilitated by a
grid back-end to manage large datasets, as there are cur-
rently more than 500,000 sequences of influenza A virus
reported in the public Influenza Research Database (IRD;
http://www.fludb.org/). g-FLUA2H is publicly available at
http://bioinfo.perdanauniversity.edu.my/g-FLUA2H.
System description
Figure 1 provides a schematic workflow summarizing
the methodology employed by g-FLUA2H. Input protein
sequences, in FASTA format, can be downloaded from
the publicly available Influenza Research Database (IRD;
http://www.fludb.org) for all worldwide, recorded animal
and human influenza viruses. There is a specific format
for the FASTA file header that needs to be followed:
“> Strain name information | Accession number | Pro-
tein name” where the strain name is essential and fol-
lows the influenza nomenclature by WHO in the format
“Antigenic type/Host/Location of sampling/Isolate ID
code/Year of sampling”. There is no specific format for
accession number and protein name, both of which are
optional. An example of a FASTA header format is
“> A/blue_winged_teal/Ohio/566/2006 | A7IRT3 | HA”.
Instructions on how to download sequences from the
FluDB in this header format are provided on the help
page of g-FLUA2H.
Both full-length and incomplete partial sequences are
considered for the analyses. Partial sequences are
included because they provide additional data, however,
they can be a source of spurious multiple sequence
alignment, which require manual editing to correct the
misalignment. Duplicate sequences for each protein are
removed if present. The non-redundant sequences of
each protein from both the animal and human hosts
of the virus are then merged for a co-alignment by use
of a local copy of MAFFT (obtained from http://mafft.
cbrc.jp/alignment/software/); MAFFT is one of the most
accurate multiple sequence alignment methods currently
available [14]. The co-alignment provides for a unified
alignment position, allowing comparison between the
two host populations. Users are provided with para-
meters to disable the removal of redundant sequences
and to remove alignment positions with a high fraction
of gaps (insertions or deletions), considered to be of low
statistical support. Additionally, users are provided with
the option to upload manually edited co-alignments as
input, in TALN format, if necessary. The sequences of
each host population are eventually separated from the
co-alignment for a position-by-position comparative
analyses.
The comparative analyses is based on a sliding win-
dow approach of size nine (1-9, 2-10, 3-11, etc) on the
separated alignments [15-17]. Each of the aligned
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overlapping nonamer (9-mer) positions represent a pos-
sible antigenic core binding domain for human leuko-
cyte antigen (HLA; human MHC) molecules and T-cell
receptors [16,17]; this assumption is based on the fact
that there are large array of HLAs with different binding
specificities in the human population [17]. Further, the
repeated associations of each amino acid in a moving,
overlapping 9-mer window can facilitate the detection of
possible sequencing errors. The sequences at each of the
9-mer positions are classified as four patterns of charac-
teristic diversity motifs that we previously defined in Hu,
Y. et al. [18] and discussed the biological implications.
Figure 1 Schematic workflow of the methodology employed by g-FLUA2H.
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In brief, the motifs are: (i) “index”, the most prevalent
sequence; (ii) “major” variant, the second most common
sequence and the single most prevalent variant of
the index, with at least one amino acid mutation; (iii)
“minor” variants, multiple different sequences, each with
an incidence (percent occurrence) less than that of the
major variant; and (iv) “unique” variants, each observed
only once. The quantification of the diversity motifs is
detailed in [18] and also described on the g-FLUA2H
help page (see Section D). The diversity motifs and their
incidences at each of the nonamer positions allow evalua-
tion of the mutation transmission dynamics and selectiv-
ity of the sequences in relation to the animal or human
hosts. Distinct sequences of any motif that contain gaps
(-) or any of the unresolved characters, including B
(asparagine or aspartic acid), J (leucine or Isoleucine), X
(unspecified or unknown amino acid), and Z (glutamine
or glutamic acid) are excluded from all analyses.
The output page of g-FLUA2H provides users with a
dropdown menu listing all the nonamer positions to view
motif data compared between the animal and human
hosts of the virus. The selection of a given nonamer posi-
tion presents users with a detailed information on the
distinct nonamer sequences at the position for both
hosts, such as their motif classifications and incidences,
amino acid substitutions relative to the index, strain
name of origin virus in animal and human hosts, host
species of the animal host, and the geographical distribu-
tion of the human host. Advanced functionalities include
multi-motif analysis and transmission selection where
users can analyse for any combination of the diversity
motifs and incidences between the hosts, and filter for
positive (the incidence of the corresponding motif is
greater in human host) or negative selections (incidence
of motif is greater in animal host). Snapshots of the key
features of g-FLUA2H are provided in Figure 2.
g-FLUA2H was built on top of the gUSE/WS-
PGRADE framework [19-23], a grid-backend with multi-
ple CPU cores (several hundreds). This was implemen-
ted not as a key distinguishing feature, but for practical
purpose to allow ease of handling large datasets, and
thus reducing computation time. The g-FLUA2H pipe-
line employs a combination of parallel compute inten-
sive and distributed compute less-intensive executions
(Figure 3).
g-FLUA2H Application: animal-to-human mutation
patterns of amino acid substitution E627K in
influenza A H5N1 and H7N9 subtypes
The amino acid substitution E627K in PB2 of the viral
polymerase complex has been reported to be crucial for
host tropism. Glutamic acid (E) is found at position 627
in most of the avian strains, whereas replacing the
amino acid with lysine (K) enhances viral replication in
humans [8,24-28]. The dynamics of this substitution
between the animal (avian) and human populations was
analyzed and compared by use of g-FLUA2H for H5N1
and H7N9 subtypes, over the time period and the geo-
graphical range of the reported data in IRD (Figure 4).
There were 2402 (avian: 2130, human: 272) and 127
(avian: 84, human: 43) PB2 sequences of H5N1 and
H7N9 reported in IRD as of May 2015 and April 2014,
respectively.
g-FLUA2H sample output for a representative nona-
mer position of H5N1 PB2 that contained this mutation
is shown in Figure 4A. At this position (623-631; align-
ment numbering), there were 21 distinct nonamer
sequences representing the reported populations of both
avian and human viruses. Both populations contained
the same index sequence AAPPEQSRM, present in
~75% of the 1380 avian and ~62% of the 208 human
virus sequences reported in the public database for this
position. Chicken (~24%) was the dominant avian
source species for this shared index sequence, followed
by duck (~20%, dropdown menu; number not shown in
Figure 4A) and many other host species (~< 4% each).
The human strains containing this sequence were iso-
lated primarily in Indonesia (~22%) and from many
other geographical regions in Asia.
The other dominant sequence AAPPKQSRM con-
tained a mutation relative to the index that corresponded
to the E627K substitution. This sequence was classified
as the major variant of the avian index, present in ~21%
of the avian sequences and corresponded to the human
major variant, present in ~30% of the human sequences.
Chicken (~14%) was also the dominant avian source for
this sequence. The human strains containing this
sequence were isolated primarily from Vietnam (~9%).
Although the E627K substitution has been reported to be
important for host tropism, it is clear here that a large
majority of H5N1 viruses that infected human did not
possess this mutation. Two of the six distinct nonamer
sequences of human viruses at this position were not pre-
sent in the avian viruses, suggesting human specific
mutations. Similarly, as many as 15 distinct nonamer
sequences appeared to be avian specific, non-existent in
the reported human viruses.
In comparison, the corresponding aligned H7N9 PB2
position (623-631) contained only six distinct nonamer
sequences representing both the avian and human
viruses (Figure 4B), and all but two (A624D; P626R &
E627K) matched to H5N1. However, unlike H5N1, the
avian and human viruses did not share the index
sequence. The avian index sequence AAPPEQSRM,
present in ~94% of the 80 sequences reported in
the public database for this position, was the same as
the human major variant, present in ~33% of the
40 human sequences reported for this position.
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Chicken (~31%) was the dominant avian source species
for this sequence, followed by duck (~16%), wild duck
(~14%), and many other host species (< 8% each) (drop-
down menu; numbers not shown in Figure 4B). The
human virus strains containing this sequence were pri-
marily isolated from various cities in mainland China.
Notably, the index sequence of the human viruses
(~68%), which contained the E627K substitution
(AAPPKQSRM), was found in the avian host population
solely as a unique sequence (~1%) in the Tree sparrow
species. The other four distinct nonamers were unique
sequences (~1% each) and appeared to be avian specific,
not present in the human viruses. There was no report
of human specific mutations for H7N9 at this position,
possibly due to the short history of the virus in the
human host.
Figure 2 Snapshots of selected g-FLUA2H features. A. Homepage interface of g-FLUA2H, which includes a brief description of the
application and links to start an analysis, check job status and get more information from the help page. B. Web-interface to upload input
sequence files, parameters to disable the removal of redundant sequences and to remove alignment positions with a high fraction of gaps
(insertions or deletions), and an option to receive email notification when the job submission is complete. C. A sample output page, providing
users with a dropdown menu listing all the nonamer positions to view motif data compared between the animal and human hosts of the virus.
The selection of a given nonamer position presents users with a detailed information on the distinct nonamer sequences at the position for
both hosts, such as their motif classifications and incidences (% occurrence), amino acid substitutions relative to the index, strain name of origin
virus in animal and human hosts, host species of the animal host, and the geographical distribution of the human host. D. Options for advanced
analyses on the results, such as multi-motif analysis and transmission selection where users can analyse for any combination of the diversity
motifs and incidences between the hosts, and filter for positive (the incidence of the corresponding motif is greater in human host) or negative
selections (incidence of motif is greater in animal host).
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Figure 3 The grid-backend of g-FLUA2H. The user interface of the web application allows input of data which then undergoes a series of
steps as part of the data processing and analysis workflow, built on top of the gUSE/WS-PGRADE framework. Depending on the computing
load, the framework manages distribution of jobs. Compute intensive executions are handled by sending jobs to a computing cluster, such as
HPC/Grid; in this case to the Academic Grid Malaysia Infrastructure (http://academicgrid.my), which is based on the EMI middleware (http://www.
eu-emi.eu). Compute less-intensive executions are sent to the distributed Desktop Grid (http://desktopgridfederation.org), based on BOINC setup
(https://boinc.berkeley.edu). Abbreviations: HPC, high performance computing; gUSE/WS-PGRADE, Grid and cloud User Support Environment/Web
Services Parallel Grid Runtime and Developer Environment; EMI, European Middleware Initiative; BOINC, Berkeley Open Infrastructure for Network
Computing.
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Figure 4 g-FLUA2H output for a representative PB2 nonamer position containing the E627K substitution, reported to be crucial for
host tropism. The representative position for H5N1 (panel A) and H7N9 (panel B) are the same, 623-631. The output provides detailed
information on the distinct nonamer sequences reported at the position for both animal and human hosts of the virus, such as their motif
classifications and incidences (% occurrence), amino acid substitutions relative to the index, strain name of origin virus in animal and human
hosts, host species of the animal host, and the geographical distribution of the human host. The dropdown menu for each of the distinct
nonamer sequences shows the animal species origin, strain names of origin virus in animal and human hosts, and geographical locations of the
viral isolate for the human host. The pie-charts show the frequency distribution of the animal host species origin and the geographical location
of the human isolates for the nonamer position as a whole, covering all the distinct sequences.
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In summary, the nonamer sequence (AAPPEQSRM)
without the E627K substitution was conserved across
both avian H5N1 and H7N9 viruses as the index
sequences, with chicken as the dominant avian source
species. However, the motif transmission pattern to
human differed; it remained as index in human H5N1
viruses, but was a major variant in human H7N9 viruses.
The sequence containing the E627K substitution
(AAPPKQSRM) was a major variant in both the avian
and human H5N1 viruses, and did not appear to be
required by all human viruses. In contrast, this substitu-
tion was only seen once (a unique variant) in the
reported avian H7N9 viruses, but was predominantly
observed in the human viruses as the index, possibly indi-
cating a role in host tropism. Furthermore, the analysis
identified human specific mutations for H5N1, suggest-
ing further adaptation in the human host. These results
merit further investigation (Tan, S. et al., manuscript in
preparation), and the small number of sequences for the
reported human viruses, particularly for H7N9, should be
treated as a caveat, with the possibility of sampling bias.
Conclusion
There is a rich metadata of information that can be
obtained from a comparative analysis of animal and
human host populations of influenza viruses. The data
above reveal a complex dynamic of animal to human
mutation transmission patterns. g-FLUA2H provides for
a detailed proteome-wide characterization of the compo-
sition and incidence of mutations present in the animal
and human host populations of influenza viruses, for a
better understanding of host tropism and possibly identi-
fying human adaptation mutations that are pan-subtype
or subtype-specific. This may contribute to the develop-
ment of tools for surveillance of influenza viruses, and
possibly to efforts for the prevention or treatment of viral
infection. Given that zoonosis (human disease caused by
animal pathogens) is not unique to influenza viruses,
g-FLUA2H may be applicable to other zoonotic diseases,
which are mostly viral origin and are emerging and re-
emerging, such as rabies, Ebola, Rift valley fever, and
Crimean-Congo hemorrhagic fever.
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